Ben Izar's lab is a pioneer in combining single cell techniques, genome-editing, and systems biology to explore the cancer field’s most pressing problems.
Including BRCA1 testing with prenatal carrier screening could identify people at risk of breast, ovarian, and pancreatic cancer at a time when cancer screening could save their lives.
A study from Columbia researchers suggests that changing a single letter in the DNA code of selected genes in T cells may supercharge cell therapies against cancer.
The association between neighborhood walkability and obesity-related cancers was stronger among women living in neighborhoods with higher levels of poverty.
Physician-scientist Neil Vasan brings the perspectives he's gained from classical singing and structural biology to his search for new breast cancer treatments.
Biomedical engineer Santiago Correa uses his expertise in nanotechnology to create injectable biomaterials that reprogram the body’s immune system to fight cancer, autoimmune disease, and infection.
When all evidence of cancer disappeared from Catherine Spina’s patient after radiation of a single metastasis, she became convinced that radiotherapy may be key to a new treatment approach.
Columbia cancer researchers have discovered how melanoma can hide from our immune system, pointing to ways drug developers might restore the tumor’s vulnerability.